| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 67,864 | 94,360 | 84,246 | 168,109 |
| Cost of revenues | 8,218 | 8,511 | 2,359 | 18,815 |
| Cost of revenues - related party | 30,645 | 38,374 | 30,988 | 59,346 |
| Gross profit | 29,001 | 47,475 | 50,899 | 89,948 |
| General and administrative expenses | 1,054,122 | 657,190 | 311,379 | 1,245,360 |
| Salary and benefits | 346,860 | -449,310 | 542,420 | 628,343 |
| Advertising and marketing | 94,073 | 177,919 | 104,914 | 258,295 |
| Investor relations | 12,451 | 2,887 | 33,319 | 106,000 |
| Stock based compensation | 1,647,821 | 26,528 | 6,601,793 | 3,120,445 |
| Total operating expenses | 3,155,327 | 415,214 | 7,593,825 | 5,358,443 |
| Loss from operations | -3,126,326 | -367,739 | -7,542,926 | -5,268,495 |
| Interest expense | NaN | 19,663 | 75,850 | 21,700 |
| Interest expense - amortization of intangible assets | 276,815 | 280,659.75* | NaN | NaN |
| Impairment of license agreement | NaN | 309,985.5* | NaN | NaN |
| Loss from settlement | NaN | -31,406* | NaN | NaN |
| Gain from debt extinguishment - related parties | NaN | -1,759,916.75* | NaN | -125,625 |
| Total other expense | -276,815 | -2,401,631 | -75,850 | -147,325 |
| Loss before income taxes | -3,403,141 | -2,769,370 | -7,618,776 | -5,415,820 |
| Net loss | -3,403,141 | -2,769,370 | -7,618,776 | -5,415,820 |
| Net income (gain) attributed to non-controlling interest | 9 | 197 | -558 | -2 |
| Net loss attributed to mangoceuticals, inc | -3,403,150 | -2,769,567 | -7,618,218 | -5,415,818 |
| Preferred stock dividend requirements | 294,000 | 882,000 | 294,000 | NaN |
| Net gain attributed to mangoceuticals, inc. common stockholders | -3,697,150 | -3,651,567 | -7,912,218 | NaN |
| Basic EPS | -0.22 | -0.363 | -0.69 | -0.57 |
| Diluted EPS | -0.22 | -0.363 | -0.69 | -0.57 |
| Basic Average Shares | 16,481,607 | 10,071,609* | 11,524,275 | NaN |
| Diluted Average Shares | 16,481,607 | 10,071,609* | 11,524,275 | 9,983,376 |
MANGOCEUTICALS, INC. (MGRX)
MANGOCEUTICALS, INC. (MGRX)